ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,235,121 | -3.1% | 333,566 | -7.6% | 0.00% | 0.0% |
| Q2 2023 | $32,227,283 | -21.1% | 361,090 | -5.3% | 0.00% | 0.0% |
| Q1 2023 | $40,861,436 | -15.2% | 381,099 | -3.5% | 0.00% | -50.0% |
| Q4 2022 | $48,213,260 | +25.0% | 394,770 | +5.7% | 0.00% | +100.0% |
| Q3 2022 | $38,580,000 | +5.6% | 373,624 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $36,548,000 | -22.4% | 393,160 | -2.0% | 0.00% | 0.0% |
| Q1 2022 | $47,070,000 | +9.3% | 401,084 | +25.3% | 0.00% | 0.0% |
| Q4 2021 | $43,062,000 | -20.3% | 320,096 | -5.6% | 0.00% | -50.0% |
| Q3 2021 | $54,046,000 | +22.4% | 339,076 | +1.0% | 0.00% | +100.0% |
| Q2 2021 | $44,170,000 | -25.5% | 335,761 | -27.1% | 0.00% | -50.0% |
| Q1 2021 | $59,322,000 | -23.1% | 460,287 | -0.5% | 0.00% | 0.0% |
| Q4 2020 | $77,163,000 | +9.8% | 462,663 | +1.6% | 0.00% | -33.3% |
| Q3 2020 | $70,256,000 | -1.8% | 455,263 | -5.9% | 0.00% | 0.0% |
| Q2 2020 | $71,541,000 | +58.5% | 483,717 | +20.7% | 0.00% | +50.0% |
| Q1 2020 | $45,131,000 | -23.4% | 400,779 | -5.4% | 0.00% | 0.0% |
| Q4 2019 | $58,924,000 | +34.8% | 423,548 | -6.7% | 0.00% | 0.0% |
| Q3 2019 | $43,728,000 | -16.4% | 453,977 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $52,304,000 | +5.0% | 454,232 | +7.3% | 0.00% | 0.0% |
| Q1 2019 | $49,835,000 | +78.2% | 423,405 | -5.1% | 0.00% | +100.0% |
| Q4 2018 | $27,962,000 | -14.4% | 446,311 | -3.2% | 0.00% | 0.0% |
| Q3 2018 | $32,663,000 | +11.9% | 460,961 | +5.1% | 0.00% | 0.0% |
| Q2 2018 | $29,188,000 | +10.0% | 438,789 | +8.1% | 0.00% | 0.0% |
| Q1 2018 | $26,539,000 | +53.6% | 405,809 | -5.9% | 0.00% | 0.0% |
| Q4 2017 | $17,279,000 | – | 431,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |